Transplantation related donors: experience of 1355 Chinese patients

Xiaojing Wang1, Haiyan Sun, Qinghua Li

  • 1Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R. China.

Insights

For Chinese patients without siblings, searching for parents or children (Type II) as stem cell donors is a viable strategy, especially if they share common HLA haplotypes. Extended related donors (Type III) are also a reasonable option in specific haplotype scenarios.

Area of Science:

  • Hematology
  • Immunogenetics
  • Transplantation Science

Background:

  • The

Purpose of the Study:

  • To evaluate the effectiveness of searching for different types of related donors (siblings, parents/children, extended relatives) for Chinese patients undergoing transplantation.
  • To analyze HLA haplotype frequencies and donor matching probabilities in a Chinese population, considering the impact of the one-child policy.

Main Methods:

  • Retrospective analysis of 1355 Chinese patients seeking related hematopoietic stem cell donors.
  • Definition of 2220 HLA haplotypes through segregation in 555 families.
  • Separate analysis of Type I (sibling), Type II (parent/child), and Type III (extended relative) donor searches.

Main Results:

  • Identified common HLA haplotypes in China, including A30-B13-DR7, A2-B46-DR9, and A33-B58-DR17.
  • The probability of a Human Leukocyte Antigen (HLA)-matched Type II donor was 2.13%, with 4.84% having one locus mismatch.
  • Common HLA haplotypes like A30-B13-DR7 were observed in HLA-matched Type II donors.

Conclusions:

  • For only children or patients lacking an HLA-matched sibling donor, searching for Type II donors is a valuable strategy, particularly with common haplotypes like A30-B13-DR7.
  • Type III donor searches remain a reasonable option when patients possess one common and one uncommon HLA haplotype.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...